Marinus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	30.99	25.48	15.35	1.72	0	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	21.63%	66.03%	793.19%	-	-	-	-	-	-	-	Upgrade
Cost of Revenue	1.93	0.34	1.48	0	0	0	0	0	0	0	Upgrade
Gross Profit	29.06	25.14	13.87	1.72	0	0	0	0	0	0	Upgrade
Selling, General & Admin	61.15	56.85	37.28	18.55	11.46	8.79	6.67	6.24	5.52	3.23	Upgrade
Research & Development	99.39	79.91	73.52	51.11	42.97	28.39	12.38	22.01	18.92	8.69	Upgrade
Other Operating Expenses	0	1.17	0	0	0.05	0	0.02	0.07	0.01	0	Upgrade
Operating Expenses	160.54	137.93	110.8	69.66	54.48	37.18	19.06	28.31	24.44	11.92	Upgrade
Operating Income	-131.49	-112.79	-96.93	-67.94	-54.48	-37.18	-19.06	-28.31	-24.44	-11.92	Upgrade
Interest Expense / Income	16.9	10.67	2.58	0	0	0	0.16	0.46	0.48	0.12	Upgrade
Other Expense / Income	-5.44	-107.03	-0.74	-0.46	-0.35	-0.45	-0.32	-0.13	-0.06	-1.2	Upgrade
Pretax Income	-142.94	-16.43	-98.78	-67.48	-54.12	-36.73	-18.9	-28.64	-24.85	-10.83	Upgrade
Income Tax	-1.54	3.39	0	0	0	0	0	0	0	0	Upgrade
Net Income	-141.41	-19.82	-98.78	-67.48	-54.12	-36.73	-18.9	-28.64	-24.85	-10.83	Upgrade
Preferred Dividends	0	0	0	8.88	0	0	0	0	0	2.55	Upgrade
Net Income Common	-141.41	-19.82	-98.78	-76.36	-54.12	-36.73	-18.9	-28.64	-24.85	-13.38	Upgrade
Shares Outstanding (Basic)	54	39	37	27	14	10	6	5	4	2	Upgrade
Shares Outstanding (Diluted)	54	39	37	27	14	10	6	5	4	2	Upgrade
Shares Change	37.56%	6.47%	34.57%	100.10%	33.30%	73.72%	20.73%	30.69%	142.49%	1228.95%	Upgrade
EPS (Basic)	-2.63	-0.51	-2.69	-2.80	-3.97	-3.60	-3.20	-5.88	-6.68	-8.68	Upgrade
EPS (Diluted)	-2.63	-0.51	-2.69	-2.80	-3.97	-3.60	-3.20	-5.88	-6.68	-8.68	Upgrade
Free Cash Flow	-118.11	-114.49	-58.37	-60.91	-49.02	-27.93	-19.27	-25.41	-20.48	-8.62	Upgrade
Free Cash Flow Per Share	-2.20	-2.93	-1.59	-2.23	-3.60	-2.73	-3.27	-5.21	-5.49	-5.61	Upgrade
Gross Margin	93.76%	98.67%	90.37%	100.00%	-	-	-	-	-	-	Upgrade
Operating Margin	-424.30%	-442.69%	-631.68%	-3954.42%	-	-	-	-	-	-	Upgrade
Profit Margin	-456.31%	-77.78%	-643.70%	-4444.41%	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-381.14%	-449.36%	-380.36%	-3545.52%	-	-	-	-	-	-	Upgrade
EBITDA	-125.31	-5.09	-95.53	-66.88	-53.62	-36.6	-18.61	-28.16	-24.36	-10.71	Upgrade
EBITDA Margin	-404.37%	-19.96%	-622.53%	-3892.72%	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	0.74	0.67	0.67	0.6	0.5	0.13	0.13	0.02	0.01	0.01	Upgrade
EBIT	-126.05	-5.76	-96.19	-67.48	-54.12	-36.73	-18.74	-28.18	-24.38	-10.72	Upgrade
EBIT Margin	-406.75%	-22.59%	-626.88%	-3927.53%	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).